Latest Insider Transactions at Akoya Biosciences, Inc. (AKYA)
This section provides a real-time view of insider transactions for Akoya Biosciences, Inc. (AKYA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Akoya Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Akoya Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 13
2022
|
Niro Ph.D Ramachandran Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,107
+37.97%
|
$0
$0.91 P/Share
|
|
Mar 23
2022
|
Frederic Pla Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+50.0%
|
-
|
|
Mar 23
2022
|
Joseph Driscoll Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
|
Mar 23
2022
|
Niro Ph.D Ramachandran Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+32.11%
|
-
|
|
Mar 23
2022
|
Brian Mc Kelligon President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+50.0%
|
-
|
|
Dec 13
2021
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
100
-0.02%
|
$1,300
$13.25 P/Share
|
|
Dec 09
2021
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
25,000
-3.68%
|
$300,000
$12.67 P/Share
|
|
Nov 22
2021
|
Niro Ph.D Ramachandran Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+49.93%
|
$325,000
$13.13 P/Share
|
|
Nov 19
2021
|
Niro Ph.D Ramachandran Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
73
+50.0%
|
$876
$12.85 P/Share
|
|
Nov 19
2021
|
Scott Mendel Director |
BUY
Open market or private purchase
|
Direct |
8,500
+50.0%
|
$110,500
$13.16 P/Share
|
|
Nov 18
2021
|
Robert G Shepler Director |
BUY
Open market or private purchase
|
Direct |
35,000
+43.18%
|
$420,000
$12.55 P/Share
|